Skip to content

SUPN - SUPERNUS PHARMACEUTICALS, INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchS

Supernus Pharmaceuticals Inc

SUPN · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

S

SUPNSupernus Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $59.68
52-wk low: $42.45
Prev close: $52.25
Mkt cap: $2.82B
Fwd P/E: 20.2x
Beta: 0.56

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$1.0B

MI
Millennium
Israel Englander · Q2 2026 13F
$179.2M
position
JS
Jim Simons
Q2 2026 13F

Earnings

Reported Aug 3, 2026

Earnings came in 30.0% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -13.2%
Forward P/E: 20.16
Market cap: $2.8B

Valuation

P/S3.40
P/B2.77

Quality

Operating margin-2.5%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: SUPN
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market cap: $2.82B
Beta: 0.56

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

3.4x

P/B

2.8x

Profit margin

-13.2%

Op margin

-2.5%

ROE

-10.5%

$68.8M

position

P7

Point72

Steven Cohen · Q1 2026 13F

$68.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for SUPN

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

$0.39+30.0%

$0.30 expected

Next report

What the street expects next

ROE

-10.5%

ROA0.4%

Growth

Beta0.56